相关实验视频
Updated: Sep 14, 2025

12:08
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
12.8K
瘤性HSV和癌症药物相互作用:当前的临床状态和未来的方向
Karina Vázquez-Arreguín1, Kimberly A Rivera-Caraballo2, Divya Ventarapragada3
1Department of Pathology, Medical College of Georgia and Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA.
概括
瘤性简单疹病毒 (oHSV) 是一种工程病毒,可以杀死瘤细胞并刺激抗瘤免疫力. 目前正在进行的临床试验探索这些病毒与药物的组合,以提高癌症治疗效率.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫治疗是一种免疫疗法.
背景情况:
- 瘤性简单疹病毒 (oHSV) 是设计用于向瘤细胞破坏和免疫刺激的工程病毒.
- 目前的oHSV疗法包括Imlygic治疗黑色素瘤和Delytact治疗脑瘤,并正在开发第二代病毒.
研究的目的:
- 总结一下癌症治疗中oHSVs的当前情况.
- 审查临床试验中病毒药物组合背后的逻辑和机制.
- 详细介绍oHSV的设计原理及其与抗瘤治疗药物的相互作用.
主要方法:
- 审查关于oHSV发展和临床试验的现有文献.
- 对病毒与药物相互作用的临床前数据的分析.
- 关于各种恶性瘤正在进行的临床研究的摘要.
主要成果:
- 第二代oHSV正在开发,以增强瘤细胞杀伤和免疫反应.
- 许多临床前研究表明oHSV与各种药物之间的协同相互作用.
- 超过100个临床试验正在评估oHSV作为单疗法或组合治疗.
结论:
- oHSV代表了对各种癌症的有前途的生物疗法,与其他疗法相结合时具有显著的潜力.
- 了解病毒与药物相互作用对于优化基于oHSV的癌症治疗策略至关重要.
- 广泛的临床试验景观表明,强烈关注推进oHSV疗法,以改善患者的治疗结果.
相关概念视频
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Cancer Vaccines
514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mechanisms of Retrovirus-induced Cancers
5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

